|
|
|
|
|
Detail |
| hsa-miR-221 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MicroRNA expression profiling in prostate cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MicroRNA signature predicts survival and relapse in lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MicroRNAs play an essential role in the development of cardiac hypertrophy. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MYCN regulates oncogenic MicroRNAs in neuroblastoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Expression profiling identifies microRNA signature in pancreatic cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Micro-RNA profiling in kidney and bladder cancers. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
The role of microRNA genes in papillary thyroid carcinoma. |
2005 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
A microRNA expression signature of human solid tumors defines cancer gene targets. |
2006 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Extensive modulation of a set of microRNAs in primary glioblastoma. |
2005 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. |
2005 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. |
2007 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MicroRNA expression and identification of putative miRNA targets in ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MicroRNA-221/222 Negatively Regulates Estrogen Receptor{alpha} and Is Associated with Tamoxifen Resistance in Breast Cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MicroRNA profile analysis of human prostate cancers. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MicroRNA-221 and -222 pathway controls melanoma progression. |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MicroRNA-dependent regulation of cKit in cutaneous melanoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
Up-regulation of micro-RNA-221 (miRNA-221; chr Xp11.3) and caspase-3 accompanies down-regulation of the survivin-1 homolog BIRC1 (NAIP) in glioblastoma multiforme(GBM). |
2008 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Clin Cancer Res. 2009 Apr 15;15(8):2850-5. Epub 2009 Apr 7. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer
cell lines. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
The expression profile of microRNAs in a model of
7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
Antisense Inhibition of microRNA-21 or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Unspecified |
miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221 |
2009 |
|
|
|
|
|
|
| hsa-miR-221 |
|
Causal |
MicroRNA-221 silencing predisposed human bladder cancer cells to undergo apoptosis induced by TRAIL |
2009 |
|
|
|
|
|
|